Blaise Félix Faye

Dr. Blaise Félix Faye

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2016 in BMC Hematology
Verified
Journal Article
Open access
PDF file
ASAbibatou Sall
Abibatou Sall
ATAwa Oumar Touré
Awa Oumar Touré
FSFatimata Bintou Sall
Fatimata Bintou Sall
Moussa NdourMoussa Ndour
Moussa Ndour
SFSeynabou Fall
Seynabou Fall
MRMartine Raphaël
Martine Raphaël
Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm characterized by the expansion of CD5-positive lymphocytes in peripheral blood. While CLL is the most common type of leukemia in Western populations, the disease is rare in Africans. Hence, clinical and laboratory data and studies of CLL in Sub Saharan populations have been limited. The aims of this study were to analyze the characteristics of senegalese patients with CLL at the time of the diagnosis and to identify the correlation between clinical characteristics (Binet stage) with age, gender, laboratory parameters and chromosomal abnormalities. In this study, we investigated the clinical and laboratory characteristics of CLL in Senegal. A total of 40 patients who had been diagnosed with CLL during the period from July 2011 to April 2015 in Senegal were evaluated. Cytology and immunophenotype were performed in all patients to confirm the diagnosis. The prognosis factors such as Binet staging, CD38 and cytogenetic abnormalities were studied. The statistical analysis was performed using STATA version 13 (Stata college station Texas). Each patient signed a free and informed consent form before participating in the study. The mean age was 61 years ranged from 48 to 85. There were 31 males and only 9 females (sex ratio M : F = 3,44). At diagnosic, 82.5 % of the patients were classified as having advanced Binet stages B or C. The prognosis marker CD38 was positive in 28 patients. Cytogenetic abnormalities studied by FISH were performed in 25 patients, among them, 68 % (17 cases) had at least one cytogenetic abnormality and 28 % had 2 simultaneous cytogenetic abnormalities. Africans may present with CLL at a younger age and our data suggest that CLL in Senegal may be more aggressive than in Western populations.

11 May 2017 in Advances in Hematology
Verified
Journal Article
Open access
PDF file
BFBlaise Félix Faye
Blaise Félix Faye
DSD. Sow
D. Sow
MSM. Seck
M. Seck
NDN. Dieng
N. Dieng
STS. A. Toure
S. A. Toure
SDS. Diop
S. Diop
Introduction. The realization of red cell exchange (RCE) in Africa faces the lack of blood, transfusion safety, and equipment. We evaluated its efficacy and safety in severe complications of sickle cell disease. Patients and Method. Manual partial RCE was performed among sickle cell patients who had severe complications. Efficacy was evaluated by clinical evolution, blood count, and electrophoresis of hemoglobin. Safety was evaluated on adverse effects, infections, and alloimmunization. Results. We performed 166 partial RCE among 44 patients including 41 homozygous (SS) and 2 heterozygous composites SC and 1 S/β0-thalassemia. The mean age was 27.9 years. The sex ratio was 1.58. The regression of symptoms was complete in 100% of persistent vasoocclusive crisis and acute chest syndrome, 56.7% of intermittent priapism, and 30% of stroke. It was partial in 100% of leg ulcers and null in acute priapism. The mean variations of hemoglobin and hematocrit rate after one procedure were, respectively, +1.4 g/dL and +4.4%. That of hemoglobin S after 2 consecutive RCE was −60%. Neither alloimmunization nor viral seroconversion was observed. Conclusion. This work shows the feasibility of manual partial RCE in a low-resource setting and its efficacy and safety during complications of SCD outside of acute priapism.

24 April 2017 in BMC Hematology
Verified
Journal Article
Open access
PDF file
MSMoussa Seck
Moussa Seck
ASAloïse Sagna
Aloïse Sagna
MGMame Sokhna Guéye
Mame Sokhna Guéye
BFBlaise Félix Faye
Blaise Félix Faye
DSDiariétou Sy
Diariétou Sy
SDSaliou Diop
Saliou Diop
Circumcision in hemophiliacs is a delicate surgery because of bleeding risks that could be avoided by adequate substitution of coagulation factor. This practice is very challenging in countries where anti hemophilic treatment is inaccessible. The study aimed to evaluate a circumcision protocol in hemophilia A using low quantities of factor concentrates. This prospective study included 26 hemophiliacs A who underwent circumcision in 2014. Medical treatment protocol using low quantity of factor concentrates was drafted by physicians of the Hemophilia Treatment Center and the surgical protocol by experienced surgeons. Assessment criteria were: number of hospitalization days, number of exposure days to factor concentrates, delay to healing and occurrence of bleeding events. Mean age was 9.6 years (1–30). Hemophiliacs patients were classified as severe (n = 8), moderate (n = 9) and mild form (n = 9). Mean number of exposure days to factor VIII concentrates was 6.9 days (5–12) in children and 10.75 days (7–16) in adults (p = 0.0049); mean number of hospitalization days was 3.68 days (2–10) in children and 13.5 days (13–15) in adults (p = 0.0000); delay to healing was 26.47 days (20–35) in children and 25.25 days (22–30) in adults (p = 0.697); five haemophiliacs (19.2%) presented bleeding events after the circumcision. The mean amount of FIII concentrates used per patient was 1743 IU (810–2340). The study shows treatment protocol using low quantity of factor concentrates is efficient in hemophilia patients who underwent circumcision.

20 March 2022 in Hematology
Verified
Journal Article
Open access
STSokhna Aissatou Touré
Sokhna Aissatou Touré
MSMoussa Seck
Moussa Seck
DSDiariatou Sy
Diariatou Sy
EBElimane Seydi Bousso
Elimane Seydi Bousso
BFBlaise Félix Faye
Blaise Félix Faye
SDSaliou Diop
Saliou Diop
Life-threatening bleeding (LTB) is one of the major complications of hemophilia with a high risk of mortality.

28 August 2017 in Hematology
Verified
Journal Article
Closed access
BFBlaise Félix Faye
Blaise Félix Faye
KKKouassi Berenger Kouame
Kouassi Berenger Kouame
MSMoussa Seck
Moussa Seck
ADAbdou Aziz Diouf
Abdou Aziz Diouf
MGMacoura Gadji
Macoura Gadji
SDSaliou Diop
Saliou Diop
Objectives: The aim of this study was to evaluate the maternal and fetal complications in pregnant patients with sickle cell disease (SCD) and find risk factors of stillbirth. Method: We conducted a prospective study in pregnant women with SCD. Demographic characteristics, maternal and fetal morbi-mortality, and outcome of pregnancies were described. Risk factors of fetal loss were evaluated by comparing the parameters of the pregnancies that led to a live birth with those interrupted. Results: We included 70 pregnancies in 58 women with SCD. The average age was 29.3 years. The average gestational age at the start of follow-up was 13 weeks. The occurrence of acute complications was significantly higher during pregnancy compared to the year before (p < 0.05). Maternal mortality was 0%. Live birth rate was 80%. Fetal loss rate was 3.9 times higher in previous pregnancies that had not been monitored in hematology (71.8 versus 18.6%). Stillbirth was associated with nulliparity, high leukocytes or platelet counts (p < 0.05). Conclusion: Pregnancy in SCD was associated with a high maternal morbidity and stillbirth. Nulliparity, high leucokocytes or platelet count were identified as risk factors of fetal loss.

2 June 2021 in Turkish Journal of Hematology
Verified
Journal Article
Open access
ASAbibatou Sall
Abibatou Sall
MSMoussa Seck
Moussa Seck
DSDiama Samb
Diama Samb
BFBlaise Félix Faye
Blaise Félix Faye
MGMacoura Gadji
Macoura Gadji
ATAwa Oumar Touré
Awa Oumar Touré